Roberts, Glore & Co’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $580K | Sell |
6,742
-55
| -0.8% | -$4.82K | 0.14% | 133 |
|
|
2026
Q1 | $615K | Sell |
6,797
-568
| -8% | -$52.1K | 0.17% | 116 |
|
|
2025
Q4 | $662K | Sell |
7,365
-760
| -9% | -$72.1K | 0.18% | 115 |
|
|
2025
Q3 | $800K | Sell |
8,125
-757
| -9% | -$75K | 0.22% | 96 |
|
|
2025
Q2 | $810K | Buy |
8,882
+489
| +6% | +$47.3K | 0.24% | 97 |
|
|
2025
Q1 | $950K | Sell |
8,393
-155
| -2% | -$16.6K | 0.29% | 84 |
|
|
2024
Q4 | $903K | Sell |
8,548
-460
| -5% | -$49.4K | 0.27% | 84 |
|
|
2024
Q3 | $972K | Buy |
9,008
+285
| +3% | +$31.1K | 0.28% | 84 |
|
|
2024
Q2 | $947K | Sell |
8,723
-90
| -1% | -$10.6K | 0.29% | 85 |
|
|
2024
Q1 | $1.16M | Buy |
8,813
+20
| +0.2% | +$2.5K | 0.35% | 77 |
|
|
2023
Q4 | $1.07M | Buy |
8,793
+150
| +2% | +$16.7K | 0.33% | 80 |
|
|
2023
Q3 | $970K | Sell |
8,643
-10
| -0.1% | -$1.27K | 0.32% | 77 |
|
|
2023
Q2 | $1.26M | Buy |
8,653
+5
| +0.1% | +$679 | 0.4% | 66 |
|
|
2023
Q1 | $1.12M | Buy |
8,648
+50
| +0.6% | +$6.28K | 0.37% | 69 |
|
|
2022
Q4 | $1.1M | Sell |
8,598
-195
| -2% | -$22.6K | 0.38% | 65 |
|
|
2022
Q3 | $919K | Hold |
8,793
| – | – | 0.33% | 75 |
|
|
2022
Q2 | $924K | Buy |
8,793
+470
| +6% | +$55.8K | 0.31% | 82 |
|
|
2022
Q1 | $1.06M | Sell |
8,323
-162
| -2% | -$19.5K | 0.31% | 78 |
|
|
2021
Q4 | $1.05M | Buy |
8,485
+280
| +3% | +$36.6K | 0.28% | 79 |
|
|
2021
Q3 | $1.17M | Hold |
8,205
| – | – | 0.35% | 70 |
|
|
2021
Q2 | $1.28M | Hold |
8,205
| – | – | 0.38% | 66 |
|
|
2021
Q1 | $1.27M | Hold |
8,205
| – | – | 0.4% | 64 |
|
|
2020
Q4 | $1.23M | Hold |
8,205
| – | – | 0.4% | 65 |
|
|
2020
Q3 | $1.08M | Hold |
8,205
| – | – | 0.39% | 64 |
|
|
2020
Q2 | $950K | Buy |
8,205
+330
| +4% | +$38K | 0.37% | 67 |
|
|
2020
Q1 | $772K | Buy |
7,875
+770
| +11% | +$101K | 0.33% | 74 |
|
|
2019
Q4 | $1.03M | Buy |
7,105
+2,141
| +43% | +$296K | 0.39% | 67 |
|
|
2019
Q3 | $662K | Hold |
4,964
| – | – | 0.41% | 72 |
|
|
2019
Q2 | $567K | Sell |
4,964
-5
| -0.1% | -$586 | 0.35% | 77 |
|
|
2019
Q1 | $616K | Hold |
4,969
| – | – | 0.39% | 71 |
|
|
2018
Q4 | $500K | Buy |
4,969
+155
| +3% | +$17.4K | 0.35% | 79 |
|
|
2018
Q3 | $614K | Buy |
4,814
+92
| +2% | +$10.9K | 0.35% | 79 |
|
|
2018
Q2 | $511K | Sell |
4,722
-15
| -0.3% | -$1.63K | 0.31% | 88 |
|
|
2018
Q1 | $501K | Hold |
4,737
| – | – | 0.31% | 85 |
|
|
2017
Q4 | $555K | Hold |
4,737
| – | – | 0.34% | 82 |
|
|
2017
Q3 | $538K | Sell |
4,737
-154
| -3% | -$17.8K | 0.35% | 81 |
|
|
2017
Q2 | $610K | Sell |
4,891
-93
| -2% | -$11K | 0.41% | 75 |
|
|
2017
Q1 | $591K | Sell |
4,984
-206
| -4% | -$23.3K | 0.41% | 73 |
|
|
2016
Q4 | $520K | Sell |
5,190
-52
| -1% | -$5.57K | 0.36% | 80 |
|
|
2016
Q3 | $662K | Sell |
5,242
-82
| -2% | -$10.1K | 0.48% | 65 |
|
|
2016
Q2 | $622K | Sell |
5,324
-197
| -4% | -$22.3K | 0.47% | 66 |
|
|
2016
Q1 | $572K | Hold |
5,521
| – | – | 0.43% | 69 |
|
|
2015
Q4 | $550K | Sell |
5,521
-77
| -1% | -$7.53K | 0.42% | 70 |
|
|
2015
Q3 | $511K | Sell |
5,598
-119
| -2% | -$11.9K | 0.4% | 73 |
|
|
2015
Q2 | $606K | Sell |
5,717
-97
| -2% | -$10.7K | 0.42% | 69 |
|
|
2015
Q1 | $663K | Sell |
5,814
-129
| -2% | -$14.7K | 0.46% | 65 |
|
|
2014
Q4 | $654K | Sell |
5,943
-10
| -0.2% | -$1.05K | 0.44% | 68 |
|
|
2014
Q3 | $581K | Sell |
5,953
-78
| -1% | -$7.67K | 0.4% | 68 |
|
|
2014
Q2 | $608K | Sell |
6,031
-2,044
| -25% | -$199K | 0.41% | 69 |
|
|
2014
Q1 | $742K | Sell |
8,075
-72
| -0.9% | -$6.64K | 0.51% | 60 |
|
|
2013
Q4 | $737K | Sell |
8,147
-103
| -1% | -$8.91K | 0.51% | 57 |
|
|
2013
Q3 | $658K | Sell |
8,250
-5,861
| -42% | -$461K | 0.49% | 60 |
|
|
2013
Q2 | $1.03M | Buy |
+14,111
| New | +$1.06M | 0.63% | 44 |
|
Other funds holding ZBH
Roberts, Glore & Co's ZBH Position: Q2 2026 in Review
Roberts, Glore & Co reduced its Zimmer Biomet (ZBH) stake by 0.81% in Q2 2026, selling an estimated $4.82K and leaving 6,742 shares worth $580K. The position accounts for 0.14% of the portfolio, ranked #133.
Roberts, Glore & Co first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.28M in Q2 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Roberts, Glore & Co held 6,742 shares of Zimmer Biomet worth $580K as of Q2 2026.
- Roberts, Glore & Co sold 55 Zimmer Biomet shares in Q2 2026, an estimated $4.82K.
- Zimmer Biomet made up 0.14% of Roberts, Glore & Co's portfolio in Q2 2026, its #133 holding.
- Roberts, Glore & Co first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- Roberts, Glore & Co's Zimmer Biomet position peaked at $1.28M in Q2 2021.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.